Skip to main content
Erschienen in: Molecular Pain 1/2009

Open Access 01.12.2009 | Short report

Behavioral phenotypes of mice lacking purinergic P2X4 receptors in acute and chronic pain assays

verfasst von: Makoto Tsuda, Kazuya Kuboyama, Tomoyuki Inoue, Kenichiro Nagata, Hidetoshi Tozaki-Saitoh, Kazuhide Inoue

Erschienen in: Molecular Pain | Ausgabe 1/2009

Abstract

A growing body of evidence indicates that P2X receptors (P2XRs), a family of ligand-gated cation channels activated by extracellular ATP, play an important role in pain signaling. In contrast to the role of the P2X3R subtype that has been extensively studied, the precise roles of others among the seven P2XR subtypes (P2X1R-P2X7R) remain to be determined because of a lack of sufficiently powerful tools to specifically block P2XR signaling in vivo. In the present study, we investigated the behavioral phenotypes of a line of mice in which the p2rx4 gene was disrupted in a series of acute and chronic pain assays. While p2rx4-/- mice showed no major defects in pain responses evoked by acute noxious stimuli and local tissue damage or in motor function as compared with wild-type mice, these mice displayed reduced pain responses in two models of chronic pain (inflammatory and neuropathic pain). In a model of chronic inflammatory pain developed by intraplantar injection of complete Freund's adjuvant (CFA), p2rx4-/- mice exhibited attenuations of pain hypersensitivity to innocuous mechanical stimuli (tactile allodynia) and also of the CFA-induced swelling of the hindpaw. A most striking phenotype was observed in a test of neuropathic pain: tactile allodynia caused by an injury to spinal nerve was markedly blunted in p2rx4-/- mice. By contrast, pain hypersensitivity to a cold stimulus (cold allodynia) after the injury was comparable in wild-type and p2rx4-/- mice. Together, these findings reveal a predominant contribution of P2X4R to nerve injury-induced tactile allodynia and, to the lesser extent, peripheral inflammation. Loss of P2X4R produced no defects in acute physiological pain or tissue damaged-induced pain, highlighting the possibility of a therapeutic benefit of blocking P2X4R in the treatment of chronic pain, especially tactile allodynia after nerve injury.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1744-8069-5-28) contains supplementary material, which is available to authorized users.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

MT designed, performed and supervised the experiments, analyzed the data, and wrote the manuscript; KK and TI performed the experiments; KN, HST. analyzed the data; KI coordinated the project, helped to interpret the data, and edited the manuscript. All authors have read and approved the final manuscript.

Findings

The purinergic P2X receptors, of which seven subtypes (P2X1–P2X7) have been cloned, are a family of ligand-gated cation channels activated by extracellular ATP. They have important roles in regulating neuronal and glial functions in the nervous system under physiological and pathological conditions [13]. There has been much recent attention paid to their roles in generating and modulating pain signaling [13]. Various attempts to block P2XRs pharmacologically or to suppress their expression molecularly and genetically have demonstrated that these receptors make a major contribution to pain responses evoked by tissue damage, chronic peripheral inflammation and nerve injury [46]. While the role of P2X3R (and P2X2+3R) has been studied extensively, recent evidence from our and other studies indicates that the P2X4R subtype critically contributes to neuropathic pain, a highly debilitating pain condition that commonly occurs after nerve damage [713]. However, the precise role of P2X4R in neuropathic pain remains to be fully determined because, in stark contrast to P2X3R [1416] and P2X7R [17, 18], there is a lack of sufficiently powerful pharmacological and genetic tools to selectively block P2X4R signaling in vivo. Recently, several groups have independently developed lines of mice in which the p2rx4 gene is disrupted [1921]. It is of particular importance to study the phenotypes of these mice to determine the in vivo functions of P2X4R in pain signaling [22]. In the present study, we sought to characterize behavioral phenotypes in a wide range of assays of acute and chronic pain, including neuropathic pain, using a line of P2X4R-deficient mice [19].
To examine acute physiological pain responses, the withdrawal responses from a noxious range of heat and mechanical stimuli applied by von Frey filaments were measured in both wild-type and p2rx4-/- mice. In tail- and paw-flick tests, the latencies for animals to flick their tails and hindpaws away from radiant heat at either 30 V or 50 V were not different between wild-type and p2rx4-/- mice (Fig. 1A, B). In a test of mechanical pain, p2rx4-/- mice were indistinguishable from wild-type mice in terms of their paw withdrawal thresholds (Fig. 1C). Abdominal writhing behavior in response to intraperitoneal injection with acetic acid, a model of chemical-induced visceral pain, was also comparable between the two lines of mice (Fig. 1D). To determine the role of P2X4R in tissue injury-induced acute and persistent pain, we assessed the pain response following the injection of formalin into the hindpaw. In wild-type mice, injection of formalin elicited biphasic biting and licking behaviors: the first phase started immediately after the injection and lasted for 5 min, and the second phase lasted for 60 min (Fig. 1E). Neither the pattern nor the magnitude of biphasic behaviors was altered in p2rx4-/- mice (Fig. 1E). The amount of swelling of the formalin-injected hindpaw, as indicated by an increase in the weight of the hindpaw 60 min after the injection, was not significantly different between the two lines of mice (contralateral hindpaw: wild-type 0.137 ± 0.008 g, p2rx4-/- 0.130 ± 0.004 g; ipsilateral: wild-type 0.173 ± 0.005 g, p2rx4-/- 0.181 ± 0.005 g). These results indicate that pain signaling elicited by acute noxious stimuli and tissue damage is intact in p2rx4-/- mice.
Next, to investigate the role of P2X4R in pain hypersensitivity under chronic pain conditions, we employed two distinct models of chronic pain, namely inflammatory and neuropathic pain. Wild-type mice with peripheral inflammation induced by intraplantar injection of complete Freund's adjuvant (CFA), used as a model of inflammatory pain, displayed decreased paw withdrawal thresholds in their ipsilateral hindpaws (Fig. 2A). By contrast, the peripheral inflammation-induced decrease in paw withdrawal threshold was significantly smaller in p2rx4-/- mice than wild-type mice. The paw withdrawal thresholds for the contralateral hindpaws in both genotypes of mice did not change (Fig. 2A). In wild-type mice, a marked swelling of the ipsilateral hindpaw was observed, and the weight of the hindpaw was increased on day 14 (Fig. 2B). In p2rx4-/- mice, however, the CFA-induced increase in the weight of the ipsilateral hindpaw was significantly suppressed (p < 0.05, Fig. 2B).
To determine the role of P2X4R in tactile allodynia under neuropathic pain conditions, we injured the forth lumbar spinal nerves of wild-type and p2rx4-/- mice; this approach has been used to generate an animal model of neuropathic pain. While wild-type mice showed a decrease in paw withdrawal threshold after nerve injury (Fig. 3A), this effect was markedly blunted in p2rx4-/- mice. The attenuated tactile allodynia was observed until the last time point tested (day 1, p < 0.05; day 3, 7, 10 and 14, p < 0.001; Fig. 3A). The loss of P2X4R did not change the paw withdrawal threshold of the contralateral hindpaw after nerve injury (Fig. 3A) as seen in wild-type mice (except on day 1, p < 0.05 vs. wild-type, Fig. 3A). A reduction in pain behaviors is occasionally misinterpreted as a result of non-specific motor dysfunction, but the rotarod performance test demonstrated no significant difference in the time on the rotarod between the two genotypes (data not shown). We further tested whether P2X4R deficiency also suppresses nerve injury-induced hypersensitivity to cold stimulation, a phenomenon known as cold allodynia. In striking contrast to the lack of nerve injury-induced tactile allodynia in p2rx4-/- mice (Fig. 3A), both wild-type and p2rx4-/- mice showed markedly enhanced responsiveness to a cold stimulus evoked by applying acetone to the ipsilateral hindpaw after nerve injury (Fig. 3B). There was no difference in the behavioral response to acetone in the contralateral hindpaw between the two lines of mice (wild-type, 3.2 ± 0.3; p2rx4-/-, 3.2 ± 0.4). These results indicate that P2X4R deficiency leads to a striking reduction in the tactile allodynia caused by nerve injury and, to the lesser extent, peripheral inflammation, without any defects in motor function.
By using P2X4R-deficient mice, we revealed that P2X4R is not required for all forms of pain responses, but rather is crucial for specialized pain states, namely chronic inflammatory and, in particular, neuropathic pain. Our present results showing the striking reduction of tactile allodynia after an injury to spinal nerves in p2rx4-/- mice together with our previous findings in rats [7] and recent findings in a line of p2rx4-/- mice after an injury to the sciatic nerve [22] provide compelling evidence for an essential role of P2X4R in nerve injury-induced tactile allodynia. To elucidate the mechanisms underlying the blunted neuropathic allodynia in p2rx4-/- mice requires further investigations, but it may involve a lack of microglial P2X4Rs in the spinal cord, expression of which is markedly upregulated after nerve injury [7, 22]. Stimulation of P2X4R in microglia induces release of brain-derived neurotrophic factor [9, 22, 23], a factor that is crucial for producing aberrant excitability of dorsal horn neurons [9, 24]. Therefore, the attenuated neuropathic allodynia in p2rx4-/- mice may be associated with a reduction in the amount of pathologically altered neurotransmission in dorsal horn neurons caused by microglia-derived BDNF [22].
An interesting finding in the present study was that nerve injury-induced cold allodynia was retained in p2rx4-/- mice, indicating that P2X4R may have distinct roles in mechanical and cold hypersensitivities after nerve injury. In a recent study it was shown that inhibition of Src-family kinases (SFKs), whose activity is enhanced in spinal microglia after nerve injury, results in suppression of tactile allodynia without affecting cold allodynia [25]. Our previous study has implicated Lyn (microglial SFK) as a critical kinase causing P2X4R upregulation [13]. It is thus conceivable that P2X4R-dependent microglial signaling in the dorsal horn may participate predominantly in allodynia evoked by mechanical rather than cold stimulation after peripheral nerve injury.
Our present study showed a reduction in the level of CFA-induced inflammatory pain in p2rx4-/- mice. In contrast to the neuropathic pain model, neither the upregulation of P2X4R expression [7] nor activation of Lyn tyrosine kinase [13] has been demonstrated in spinal microglia following peripheral inflammation caused by CFA. The mechanisms underlying the reduction in the amount of inflammatory pain remain unknown, but the phenotype may be related to a reduction in hindpaw inflammation in p2rx4-/- mice. This notion is supported by evidence of expression of functional P2X4Rs in peripheral inflammatory cells, including macrophages [21, 26].
In conclusion, by employing a series of acute and chronic pain tests using mice lacking P2X4R, we demonstrated that the loss of P2X4R leads to a marked reduction in the degree of tactile allodynia caused by nerve injury and, to a lesser extent, in peripheral inflammation, without any defects in motor function. By contrasting the roles of P2X4R in distinct types of nerve injury-induced pain hypersensitivities, namely tactile and cold allodynia, the present study demonstrates a predominant contribution of P2X4R to tactile allodynia rather than cold allodynia. The fact that acute physiological pain and tissue damage-induced pain were normal in p2rx4-/- mice highlights the possibility of a therapeutic benefit of blocking P2X4R in the treatment of chronic pain, especially tactile allodynia after nerve injury.

Methods

Animals

All experimental procedures were performed under the guidelines of Kyushu University. Male mice lacking P2X4R (p2rx4-/-) that were backcrossed to C57BL/6J (Clea Japan) for more than 10 generations were kindly provided by Prof. Joji Ando (The University of Tokyo) [19], and we used C57BL/6J as the corresponding control mice. All mice were used at age of 9~11-week-old (at the start of each experiment). Mice were housed in groups of 2~3 per cage at a temperature of 22 ± 1°C with a 12-h light-dark cycle (light on 8:30 to 20:30), and fed food and water ad libitum.

Behavioral assays for acute and chronic pain

Noxious heat-evoked tail and hindpaw withdrawal responses were detected by the application of radiant heat (Ugo Basile, Italy) to the tail and the plantar surface of hindpaw, respectively [27, 28]. The intensity of the heat stimulus was adjusted to 30 or 50 V, and the latency of the paw withdrawal response (sec) was measured. The sensitivity to mechanical stimulus was assessed using von Frey filaments (0.02~2.0 g, Stoelting, Wood Dale, Illinois, USA), and the mechanical stimulus producing the 50% paw withdrawal threshold was determined using the up-down method [29, 30]. In the tests of formalin-induced pain, mice were injected intraplantarly with formalin (5%, 20 μL), and then the duration of the licking and biting responses to the injected hindpaw was recorded at 5 min intervals for 60 min after the injection (formalin pain) [31, 32]. For the measurement of hindpaw swelling by formalin, the weights of the hind feet amputated at the ankle were measured 60 min and 14 days after the injection of formalin and CFA, respectively [32]. In the chemical visceral pain test, mice were injected intraperitoneally with acetic acid (0.8%), and the number of abdominal writhes was counted for 5 min starting from 5 min after the injection [32]. Motor coordination was assessed using the rotarod performance test [31]. For the inflammatory pain model, CFA (0.01 mg/20 μL) was injected into the plantar surface of the left hindpaw [13]. For the neuropathic pain model, the left L4 spinal nerve of mice was transected under isoflurane (2%) anesthesia [3335]. To assess the tactile allodynia, mice were placed individually in an opaque plastic cylinder which was placed on a wire mesh and habituated for 1 hr to allow acclimatization to the new environment. After that, calibrated von Frey filaments (0.02–2.0 g, Stoelting) were applied to the plantar surface of the hindpaw from below the mesh floor, and the 50% paw withdrawal threshold was determined. To assess cold allodynia [36], a drop (50 μL) of acetone was placed against the centre of the plantar surface of the hindpaw and a stopwatch was started. The mouse's response was monitored in the first 20 sec after acetone application. If the mouse did not withdraw, flick or stamp its hindpaw within this 20-sec period then no response was recorded for that trial (0). However, if within this 20 sec period the animal responded to the cooling effect of the acetone, then the animal's response was assessed for an additional 20 sec (a total of 40 sec from initial application). Responses to acetone were graded according to the following four-point scale: 0, no response; 1, quick withdrawal, flick or stamp of the paw; 2, prolonged withdrawal or repeated flicking (more than 2 times) of the paw; 3, repeated flicking of the paw with licking directed at the plantar surface of the hindpaw. Acetone was applied alternately five times to each hindpaw and the responses were scored categorically. Cumulative scores were then generated for each mouse.

Statistical Analysis

The statistical analyses of the results were evaluated by using the Student’s t test or the Mann-Whitney U test.

Acknowledgements

We thank Dr. Joji Ando (The University of Tokyo) for providing P2X4R-knockout mice. This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to M.T., K.I.).
Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://​creativecommons.​org/​licenses/​by/​2.​0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

MT designed, performed and supervised the experiments, analyzed the data, and wrote the manuscript; KK and TI performed the experiments; KN, HST. analyzed the data; KI coordinated the project, helped to interpret the data, and edited the manuscript. All authors have read and approved the final manuscript.
Anhänge

Authors’ original submitted files for images

Literatur
2.
Zurück zum Zitat Khakh BS, North RA: P2X receptors as cell-surface ATP sensors in health and disease. Nature 2006, 442: 527–532.CrossRef Khakh BS, North RA: P2X receptors as cell-surface ATP sensors in health and disease. Nature 2006, 442: 527–532.CrossRef
3.
Zurück zum Zitat Burnstock G: Purinergic signalling and disorders of the central nervous system. Nat Rev Drug Discov 2008, 7: 575–590.CrossRef Burnstock G: Purinergic signalling and disorders of the central nervous system. Nat Rev Drug Discov 2008, 7: 575–590.CrossRef
4.
Zurück zum Zitat Burnstock G: Purinergic P2 receptors as targets for novel analgesics. Pharmacol Ther 2006, 110: 433–454.CrossRef Burnstock G: Purinergic P2 receptors as targets for novel analgesics. Pharmacol Ther 2006, 110: 433–454.CrossRef
5.
Zurück zum Zitat Nakatsuka T, Gu JG: P2X purinoceptors and sensory transmission. Pflugers Arch 2006, 452: 598–607.CrossRef Nakatsuka T, Gu JG: P2X purinoceptors and sensory transmission. Pflugers Arch 2006, 452: 598–607.CrossRef
6.
Zurück zum Zitat Tsuda M, Inoue K: Chapter 9 – P2X Receptors in Sensory Neurons. In The Nociceptive Membrane. Volume 57. Edited by: Oh U. San Diego: Academic Press; 2006:277–310.CrossRef Tsuda M, Inoue K: Chapter 9 – P2X Receptors in Sensory Neurons. In The Nociceptive Membrane. Volume 57. Edited by: Oh U. San Diego: Academic Press; 2006:277–310.CrossRef
7.
Zurück zum Zitat Tsuda M, Shigemoto-Mogami Y, Koizumi S, Mizokoshi A, Kohsaka S, Salter MW, Inoue K: P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 2003, 424: 778–783.CrossRef Tsuda M, Shigemoto-Mogami Y, Koizumi S, Mizokoshi A, Kohsaka S, Salter MW, Inoue K: P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 2003, 424: 778–783.CrossRef
8.
Zurück zum Zitat Tsuda M, Inoue K, Salter MW: Neuropathic pain and spinal microglia: a big problem from molecules in "small" glia. Trends Neurosci 2005, 28: 101–107.CrossRef Tsuda M, Inoue K, Salter MW: Neuropathic pain and spinal microglia: a big problem from molecules in "small" glia. Trends Neurosci 2005, 28: 101–107.CrossRef
9.
Zurück zum Zitat Coull JA, Beggs S, Boudreau D, Boivin D, Tsuda M, Inoue K, Gravel C, Salter MW, De Koninck Y: BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 2005, 438: 1017–1021.CrossRef Coull JA, Beggs S, Boudreau D, Boivin D, Tsuda M, Inoue K, Gravel C, Salter MW, De Koninck Y: BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 2005, 438: 1017–1021.CrossRef
10.
Zurück zum Zitat Trang T, Beggs S, Salter MW: Purinoceptors in microglia and neuropathic pain. Pflugers Arch 2006, 452: 645–652.CrossRef Trang T, Beggs S, Salter MW: Purinoceptors in microglia and neuropathic pain. Pflugers Arch 2006, 452: 645–652.CrossRef
11.
Zurück zum Zitat Scholz J, Woolf CJ: The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 2007, 10: 1361–1368.CrossRef Scholz J, Woolf CJ: The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 2007, 10: 1361–1368.CrossRef
12.
Zurück zum Zitat Tsuda M, Toyomitsu E, Komatsu T, Masuda T, Kunifusa E, Nasu-Tada K, Koizumi S, Yamamoto K, Ando J, Inoue K: Fibronectin/integrin system is involved in P2X(4) receptor upregulation in the spinal cord and neuropathic pain after nerve injury. Glia 2008, 56: 579–585.CrossRef Tsuda M, Toyomitsu E, Komatsu T, Masuda T, Kunifusa E, Nasu-Tada K, Koizumi S, Yamamoto K, Ando J, Inoue K: Fibronectin/integrin system is involved in P2X(4) receptor upregulation in the spinal cord and neuropathic pain after nerve injury. Glia 2008, 56: 579–585.CrossRef
13.
Zurück zum Zitat Tsuda M, Tozaki-Saitoh H, Masuda T, Toyomitsu E, Tezuka T, Yamamoto T, Inoue K: Lyn tyrosine kinase is required for P2X(4) receptor upregulation and neuropathic pain after peripheral nerve injury. Glia 2008, 56: 50–58.CrossRef Tsuda M, Tozaki-Saitoh H, Masuda T, Toyomitsu E, Tezuka T, Yamamoto T, Inoue K: Lyn tyrosine kinase is required for P2X(4) receptor upregulation and neuropathic pain after peripheral nerve injury. Glia 2008, 56: 50–58.CrossRef
14.
Zurück zum Zitat Cockayne DA, Hamilton SG, Zhu QM, Dunn PM, Zhong Y, Novakovic S, Malmberg AB, Cain G, Berson A, Kassotakis L, et al.: Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature 2000, 407: 1011–1015.CrossRef Cockayne DA, Hamilton SG, Zhu QM, Dunn PM, Zhong Y, Novakovic S, Malmberg AB, Cain G, Berson A, Kassotakis L, et al.: Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature 2000, 407: 1011–1015.CrossRef
15.
Zurück zum Zitat Souslova V, Cesare P, Ding Y, Akopian AN, Stanfa L, Suzuki R, Carpenter K, Dickenson A, Boyce S, Hill R, et al.: Warm-coding deficits and aberrant inflammatory pain in mice lacking P2X3 receptors. Nature 2000, 407: 1015–1017.CrossRef Souslova V, Cesare P, Ding Y, Akopian AN, Stanfa L, Suzuki R, Carpenter K, Dickenson A, Boyce S, Hill R, et al.: Warm-coding deficits and aberrant inflammatory pain in mice lacking P2X3 receptors. Nature 2000, 407: 1015–1017.CrossRef
16.
Zurück zum Zitat Jarvis MF, Burgard EC, McGaraughty S, Honore P, Lynch K, Brennan TJ, Subieta A, Van Biesen T, Cartmell J, Bianchi B, et al.: A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat. Proc Natl Acad Sci USA 2002, 99: 17179–17184.PubMedCentralCrossRef Jarvis MF, Burgard EC, McGaraughty S, Honore P, Lynch K, Brennan TJ, Subieta A, Van Biesen T, Cartmell J, Bianchi B, et al.: A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat. Proc Natl Acad Sci USA 2002, 99: 17179–17184.PubMedCentralCrossRef
17.
Zurück zum Zitat Chessell IP, Hatcher JP, Bountra C, Michel AD, Hughes JP, Green P, Egerton J, Murfin M, Richardson J, Peck WL, et al.: Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 2005, 114: 386–396.CrossRef Chessell IP, Hatcher JP, Bountra C, Michel AD, Hughes JP, Green P, Egerton J, Murfin M, Richardson J, Peck WL, et al.: Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 2005, 114: 386–396.CrossRef
18.
Zurück zum Zitat Honore P, Donnelly-Roberts D, Namovic MT, Hsieh G, Zhu CZ, Mikusa JP, Hernandez G, Zhong C, Gauvin DM, Chandran P, et al.: A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat. J Pharmacol Exp Ther 2006, 319: 1376–1385.CrossRef Honore P, Donnelly-Roberts D, Namovic MT, Hsieh G, Zhu CZ, Mikusa JP, Hernandez G, Zhong C, Gauvin DM, Chandran P, et al.: A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat. J Pharmacol Exp Ther 2006, 319: 1376–1385.CrossRef
19.
Zurück zum Zitat Yamamoto K, Sokabe T, Matsumoto T, Yoshimura K, Shibata M, Ohura N, Fukuda T, Sato T, Sekine K, Kato S, et al.: Impaired flow-dependent control of vascular tone and remodeling in P2X4-deficient mice. Nat Med 2006, 12: 133–137.CrossRef Yamamoto K, Sokabe T, Matsumoto T, Yoshimura K, Shibata M, Ohura N, Fukuda T, Sato T, Sekine K, Kato S, et al.: Impaired flow-dependent control of vascular tone and remodeling in P2X4-deficient mice. Nat Med 2006, 12: 133–137.CrossRef
20.
Zurück zum Zitat Sim JA, Chaumont S, Jo J, Ulmann L, Young MT, Cho K, Buell G, North RA, Rassendren F: Altered hippocampal synaptic potentiation in P2X4 knock-out mice. J Neurosci 2006, 26: 9006–9009.CrossRef Sim JA, Chaumont S, Jo J, Ulmann L, Young MT, Cho K, Buell G, North RA, Rassendren F: Altered hippocampal synaptic potentiation in P2X4 knock-out mice. J Neurosci 2006, 26: 9006–9009.CrossRef
21.
Zurück zum Zitat Brone B, Moechars D, Marrannes R, Mercken M, Meert T: P2X currents in peritoneal macrophages of wild type and P2X4 -/- mice. Immunol Lett 2007, 113: 83–89.CrossRef Brone B, Moechars D, Marrannes R, Mercken M, Meert T: P2X currents in peritoneal macrophages of wild type and P2X4 -/- mice. Immunol Lett 2007, 113: 83–89.CrossRef
22.
Zurück zum Zitat Ulmann L, Hatcher JP, Hughes JP, Chaumont S, Green PJ, Conquet F, Buell GN, Reeve AJ, Chessell IP, Rassendren F: Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. J Neurosci 2008, 28: 11263–11268.CrossRef Ulmann L, Hatcher JP, Hughes JP, Chaumont S, Green PJ, Conquet F, Buell GN, Reeve AJ, Chessell IP, Rassendren F: Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. J Neurosci 2008, 28: 11263–11268.CrossRef
23.
Zurück zum Zitat Trang T, Beggs S, Wan X, Salter MW: P2X4-receptor-mediated synthesis and release of brain-derived neurotrophic factor in microglia is dependent on calcium and p38-mitogen-activated protein kinase activation. J Neurosci 2009, 29: 3518–3528.PubMedCentralCrossRef Trang T, Beggs S, Wan X, Salter MW: P2X4-receptor-mediated synthesis and release of brain-derived neurotrophic factor in microglia is dependent on calcium and p38-mitogen-activated protein kinase activation. J Neurosci 2009, 29: 3518–3528.PubMedCentralCrossRef
24.
Zurück zum Zitat Keller AF, Beggs S, Salter MW, De Koninck Y: Transformation of the output of spinal lamina I neurons after nerve injury and microglia stimulation underlying neuropathic pain. Mol Pain 2007, 3: 27.PubMedCentralCrossRef Keller AF, Beggs S, Salter MW, De Koninck Y: Transformation of the output of spinal lamina I neurons after nerve injury and microglia stimulation underlying neuropathic pain. Mol Pain 2007, 3: 27.PubMedCentralCrossRef
25.
Zurück zum Zitat Katsura H, Obata K, Mizushima T, Sakurai J, Kobayashi K, Yamanaka H, Dai Y, Fukuoka T, Sakagami M, Noguchi K: Activation of Src-family kinases in spinal microglia contributes to mechanical hypersensitivity after nerve injury. J Neurosci 2006, 26: 8680–8690.CrossRef Katsura H, Obata K, Mizushima T, Sakurai J, Kobayashi K, Yamanaka H, Dai Y, Fukuoka T, Sakagami M, Noguchi K: Activation of Src-family kinases in spinal microglia contributes to mechanical hypersensitivity after nerve injury. J Neurosci 2006, 26: 8680–8690.CrossRef
26.
Zurück zum Zitat Bowler JW, Bailey RJ, North RA, Surprenant A: P2X4, P2Y1 and P2Y2 receptors on rat alveolar macrophages. Br J Pharmacol 2003, 140: 567–575.PubMedCentralCrossRef Bowler JW, Bailey RJ, North RA, Surprenant A: P2X4, P2Y1 and P2Y2 receptors on rat alveolar macrophages. Br J Pharmacol 2003, 140: 567–575.PubMedCentralCrossRef
27.
Zurück zum Zitat Tsuda M, Ueno S, Inoue K: In vivo pathway of thermal hyperalgesia by intrathecal administration of alpha,beta-methylene ATP in mouse spinal cord: involvement of the glutamate-NMDA receptor system. Br J Pharmacol 1999, 127: 449–456.PubMedCentralCrossRef Tsuda M, Ueno S, Inoue K: In vivo pathway of thermal hyperalgesia by intrathecal administration of alpha,beta-methylene ATP in mouse spinal cord: involvement of the glutamate-NMDA receptor system. Br J Pharmacol 1999, 127: 449–456.PubMedCentralCrossRef
28.
Zurück zum Zitat Tsuda M, Koizumi S, Kita A, Shigemoto Y, Ueno S, Inoue K: Mechanical allodynia caused by intraplantar injection of P2X receptor agonist in rats: involvement of heteromeric P2X2/3 receptor signaling in capsaicin-insensitive primary afferent neurons. J Neurosci 2000, 20: RC90. Tsuda M, Koizumi S, Kita A, Shigemoto Y, Ueno S, Inoue K: Mechanical allodynia caused by intraplantar injection of P2X receptor agonist in rats: involvement of heteromeric P2X2/3 receptor signaling in capsaicin-insensitive primary afferent neurons. J Neurosci 2000, 20: RC90.
29.
Zurück zum Zitat Dixon WJ: Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol 1980, 20: 441–462.CrossRef Dixon WJ: Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol 1980, 20: 441–462.CrossRef
30.
Zurück zum Zitat Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL: Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994, 53: 55–63.CrossRef Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL: Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994, 53: 55–63.CrossRef
31.
Zurück zum Zitat Tsuda M, Ueno S, Inoue K: Evidence for the involvement of spinal endogenous ATP and P2X receptors in nociceptive responses caused by formalin and capsaicin in mice. Br J Pharmacol 1999, 128: 1497–1504.PubMedCentralCrossRef Tsuda M, Ueno S, Inoue K: Evidence for the involvement of spinal endogenous ATP and P2X receptors in nociceptive responses caused by formalin and capsaicin in mice. Br J Pharmacol 1999, 128: 1497–1504.PubMedCentralCrossRef
32.
Zurück zum Zitat Tsuda M, Ishii S, Masuda T, Hasegawa S, Nakamura K, Nagata K, Yamashita T, Furue H, Tozaki-Saitoh H, Yoshimura M, et al.: Reduced pain behaviors and extracellular signal-related protein kinase activation in primary sensory neurons by peripheral tissue injury in mice lacking platelet-activating factor receptor. J Neurochem 2007, 102: 1658–1668.CrossRef Tsuda M, Ishii S, Masuda T, Hasegawa S, Nakamura K, Nagata K, Yamashita T, Furue H, Tozaki-Saitoh H, Yoshimura M, et al.: Reduced pain behaviors and extracellular signal-related protein kinase activation in primary sensory neurons by peripheral tissue injury in mice lacking platelet-activating factor receptor. J Neurochem 2007, 102: 1658–1668.CrossRef
33.
Zurück zum Zitat Kim SH, Chung JM: An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992, 50: 355–363.CrossRef Kim SH, Chung JM: An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992, 50: 355–363.CrossRef
34.
Zurück zum Zitat Tozaki-Saitoh H, Tsuda M, Miyata H, Ueda K, Kohsaka S, Inoue K: P2Y12 receptors in spinal microglia are required for neuropathic pain after peripheral nerve injury. J Neurosci 2008, 28: 4949–4956.CrossRef Tozaki-Saitoh H, Tsuda M, Miyata H, Ueda K, Kohsaka S, Inoue K: P2Y12 receptors in spinal microglia are required for neuropathic pain after peripheral nerve injury. J Neurosci 2008, 28: 4949–4956.CrossRef
35.
Zurück zum Zitat Rigaud M, Gemes G, Barabas ME, Chernoff DI, Abram SE, Stucky CL, Hogan QH: Species and strain differences in rodent sciatic nerve anatomy: implications for studies of neuropathic pain. Pain 2008, 136: 188–201.PubMedCentralCrossRef Rigaud M, Gemes G, Barabas ME, Chernoff DI, Abram SE, Stucky CL, Hogan QH: Species and strain differences in rodent sciatic nerve anatomy: implications for studies of neuropathic pain. Pain 2008, 136: 188–201.PubMedCentralCrossRef
36.
Zurück zum Zitat Flatters SJ, Bennett GJ: Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy. Pain 2004, 109: 150–161.CrossRef Flatters SJ, Bennett GJ: Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy. Pain 2004, 109: 150–161.CrossRef
Metadaten
Titel
Behavioral phenotypes of mice lacking purinergic P2X4 receptors in acute and chronic pain assays
verfasst von
Makoto Tsuda
Kazuya Kuboyama
Tomoyuki Inoue
Kenichiro Nagata
Hidetoshi Tozaki-Saitoh
Kazuhide Inoue
Publikationsdatum
01.12.2009
Verlag
BioMed Central
Erschienen in
Molecular Pain / Ausgabe 1/2009
Elektronische ISSN: 1744-8069
DOI
https://doi.org/10.1186/1744-8069-5-28

Weitere Artikel der Ausgabe 1/2009

Molecular Pain 1/2009 Zur Ausgabe

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.